Basal Cell Nevus Syndrome Drug Market: FDA Approved Vismodegib Proves to Be Efficacious
Basal cell nevus syndrome inflicts many areas of the body and intensifies the vulnerability of developing different cancerous and non-cancerous tumors. Individuals with basal cell nevus syndrome have comparatively more prone developing other tumors than the general population. An array of skeletal and other developmental abnormalities are normally witnessed in people with the syndrome which is caused by defects in hedgehog signaling that leads to constitutive pathway activity and tumor cell proliferation. These insights are according to the report titled,...
View full press release